Alcoholism is a substantial medical and social problem in the U.S. and relapse represents a majorchallenge to treatment efforts. Currently, there is no therapeutic intervention that is fully satisfactory inpreventing relapse and sustaining abstinence. While dependence is known to contribute to the problem ofrelapse, this issue has not been thoroughly studied. The focus and overall objective of this proposal is toutilize a mouse model of EtOH dependence and relapse to evaluate the ability of pharmacotherapies toreduce voluntary EtOH drinking, as well as neurochemical alterations that may underlie motivation todrink in dependent compared to non-dependent animals. A contemporary view of alcohol and drugaddiction indicates that activation of different neurochemical systems within the brain reward ('motive')circuitry play a critical role in establishing the initial reinforcing effects of EtOH, as well as shapingmotivational forces that perpetuate EtOH use/abuse during later stages in addiction. The mesolimbicdopamine pathway, with the nucleus accumbens being a key target structure, is a prominent componentof this circuitry. Among several neurotransmitter systems that impinge on this dopamine pathway,glutamate transmission has emerged as a key player in contributing to the motivational effects of EtOH. Aguiding principle of this proposal is that activation of the mesolimbic dopamine pathway plays an importantrole in establishing the acute reinforcing properties of EtOH, while adaptive changes in dopamine andglutamate transmission contribute to conditions that promote relapse and engender excessive EtOHdrinking behavior characteristic of dependence. The research plan entails use of in vivo microdialysisprocedures to characterize changes in extracellular levels of dopamine and glutamate in nucleusaccumbens associated with voluntary EtOH drinking, as well as evaluation of various pharmacologicalagents for their ability to influence concomitant measures of behavior (drinking) and associatedneurochemical changes in the model of dependence and relapse. The overall goal of the proposal is toprovide new information about neural substrates underlying EtOH drinking in dependent compared to nondependentsubjects, as well as evaluate the ability of potential pharmacotherapeutics to impact bothneurochemical and behavioral (drinking) changes related to dependence and relapse.

Agency
National Institute of Health (NIH)
Institute
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Type
Specialized Center (P50)
Project #
2P50AA010761-11
Application #
7226601
Study Section
Special Emphasis Panel (ZAA1-HH (60))
Project Start
2005-12-01
Project End
2010-12-31
Budget Start
2005-12-01
Budget End
2006-12-31
Support Year
11
Fiscal Year
2006
Total Cost
$241,937
Indirect Cost
Name
Medical University of South Carolina
Department
Type
DUNS #
183710748
City
Charleston
State
SC
Country
United States
Zip Code
29425
Zamudio-Bulcock, Paula A; Homanics, Gregg E; Woodward, John J (2018) Loss of Ethanol Inhibition of N-Methyl-D-Aspartate Receptor-Mediated Currents and Plasticity of Cerebellar Synapses in Mice Expressing the GluN1(F639A) Subunit. Alcohol Clin Exp Res 42:698-705
Cannady, Reginald; Rinker, Jennifer A; Nimitvilai, Sudarat et al. (2018) Chronic Alcohol, Intrinsic Excitability, and Potassium Channels: Neuroadaptations and Drinking Behavior. Handb Exp Pharmacol 248:311
Harlan, Benjamin A; Becker, Howard C; Woodward, John J et al. (2018) Opposing actions of CRF-R1 and CB1 receptors on VTA-GABAergic plasticity following chronic exposure to ethanol. Neuropsychopharmacology 43:2064-2074
Hanlon, Colleen A; Dowdle, Logan T; Henderson, J Scott (2018) Modulating Neural Circuits with Transcranial Magnetic Stimulation: Implications for Addiction Treatment Development. Pharmacol Rev 70:661-683
Hanlon, Colleen A; Dowdle, Logan T; Gibson, Nicole B et al. (2018) Cortical substrates of cue-reactivity in multiple substance dependent populations: transdiagnostic relevance of the medial prefrontal cortex. Transl Psychiatry 8:186
Gioia, Dominic A; Xu, Minfu; Wayman, Wesley N et al. (2018) Effects of drugs of abuse on channelrhodopsin-2 function. Neuropharmacology 135:316-327
Anton, Raymond F; Latham, Patricia K; Voronin, Konstantin E et al. (2018) Nicotine-Use/Smoking Is Associated with the Efficacy of Naltrexone in the Treatment of Alcohol Dependence. Alcohol Clin Exp Res 42:751-760
Anderson, Ethan M; Larson, Erin B; Guzman, Daniel et al. (2018) Overexpression of the Histone Dimethyltransferase G9a in Nucleus Accumbens Shell Increases Cocaine Self-Administration, Stress-Induced Reinstatement, and Anxiety. J Neurosci 38:803-813
Osterndorff-Kahanek, Elizabeth A; Tiwari, Gayatri R; Lopez, Marcelo F et al. (2018) Long-term ethanol exposure: Temporal pattern of microRNA expression and associated mRNA gene networks in mouse brain. PLoS One 13:e0190841
Stewart, Scott H; Reuben, Adrian; Anton, Raymond F (2018) Reply: Carbohydrate Deficient Transferrin in Patients with Cirrhosis: A Tale of Bridges. Alcohol Alcohol 53:351-352

Showing the most recent 10 out of 209 publications